ClinicalTrials.Veeva

Menu

Evaluation of Neuroinflamation of SAH (BAP)

B

Bezmialem Vakif University

Status

Unknown

Conditions

Subarachnoid Hemorrhage, Aneurysmal

Treatments

Diagnostic Test: Bezmialem VAkif Unv. Ethical board

Study type

Observational

Funder types

Other

Identifiers

NCT03822260
TD -001

Details and patient eligibility

About

The investigators are planning that can these markers be used a predictive marker at SAH and for this aim we will study both patiens' blood sample and their CT image.

Full description

An ideal marker which could be used clinically should meet numerous criteria, such as high sensitivity or the possibility of easy and quick assessment of its concentration in blood or blood plasma.The Fisher's scale presents an alternative for evaluating patients with subarachnoid hemorrhage . The investigator are going to evaluate both plasma markers and fishers scale at SAH.

Enrollment

54 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Ruptured Subarachnoid Aneursym

Exclusion criteria

  • without aneursymal sah
  • Patient's positive for rheumatoid factor and anti-CCP or with chronic inflammatory diseases (such as ankylosing spondylitis or rheumatoid arthritis), systemic diseases (such as hypercholesterolemia, hypertension, diabetes mellitus, myocardial infarction, stroke, peripheral artery disease), active infection, a history of term medication, trauma to the hip and smoking were excluded from the study.

Trial design

54 participants in 1 patient group

Sur1/ Trpm 4 acitivities at SAH
Description:
only after collecting sample,
Treatment:
Diagnostic Test: Bezmialem VAkif Unv. Ethical board

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems